SCHEMBL15516007

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL23699581	0.86	KIT (0.55)	KITPDGFRB
	SCHEMBL15689394	0.82	KIT (1.00)	KIT
	SCHEMBL15689398	0.80	KIT (0.70)	KITPDGFRBNAMPT
	SCHEMBL17282985	0.79	KIT (0.69)	KITPDGFRB
	SCHEMBL23699590	0.79	KIT (0.52)	KITPDGFRB
	SCHEMBL15665162	0.78	KIT (0.56)	KITPDGFRB
	SCHEMBL2916238	0.76	KIT (0.62)	KITPDGFRB
	SCHEMBL17274870	0.76	KIT (0.65)	KITPTPN11PDGFRB
	SCHEMBL15665163	0.76	KIT (0.72)	KIT
	SCHEMBL30945074	0.75	KIT (0.64)	KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.